Aperio Beauty

Prior to Aperio, Dr. Radfar was Co-Founder and CEO of Neolitics, a revenue stage spectroscopy company offering analytic solutions across the chemical / petrochemical, food and beverage, and pharmaceutical sectors. Prior to Neolitics, Dr. Radfar was a co-founder of the International Federation of Adipose Therapeutics and Science, a non-profit organization focused on adipose-derived stem cells, and their application towards tissue regeneration and therapeutics. He holds an M.D. from the University of Pittsburgh School of Medicine. During his medical school training, Ali spent 2 years working as a molecular genetics research associate, with a focus on applying novel gene therapy vehicles towards effecting scarless wound healing, in the context of both clinical medicine as well as aesthetics. It was through this experience, that he developed a keen appreciation of molecular genetics, as it may be applied towards the healing of skin and complex supporting skin structures. Dr. Radfar is also a Phi Beta Kappa honors graduate of John Hopkins University, having earned a Bachelor of Arts degree in Molecular Cell Biology.

Prior to Aperio Beauty, Terry has been a professional in the financial services industry for 5+ years, advising clients in the biopharma, life sciences, and diagnostics spaces, on strategic alternatives. He most recently worked at Perella Weinberg Partners as an Associate in their San Francisco office. Terry holds a B.S. degree in Finance and Marketing from New York University’s Leonard N. Stern School of Business.

Jerry is the prior Founder and CEO of the National Association of Manufacturers, the largest global organization serving the manufacturing industry. Jerry serves as a Board Member of several publicly-traded corporations. Jerry brings to Aperio a vast global network of business leaders, to help drive Aperio value through investment, strategic insight, and business to business partnerships.

Charlie is a Co-Founder and Managing Partner at Stone Pier Advisors, leading Middle Atlantic investment bank. Charlie has served previously as the Head of Life Sciences Law (Jones Day) and Head of Corporate VC for Bayer AG. Charlie offers Aperio insight into complex, often cross-border joint ventures and distribution relationships, in addition to M&A.

Gloria is the Founder of Story Partners, a premier public affairs and public relations firm, with expertise in complex communications on behalf of government, technology, healthcare, energy and transportation organizations. Gloria and past / current businesses have provided transformative guidance on managing national disasters and pandemics, including the resurrection of New Orleans following Hurricane Katrina, as well as providing complex organizational guidance to the U.S. Government in the presence of the COVID-19 pandemic. Gloria brings to Aperio a global network of strategic contacts in the Wellness and Luxury Products segments.

Dr. Tina Alster is the Founding Director of the Washington Institute of Dermatologic Laser Surgery and is a Clinical Professor of Dermatology at Georgetown University Medical Center, in Washington, D.C. She is one of the world’s foremost authorities on dermatologic laser surgery as well as aesthetic and clinical dermatology, authoring 8 textbooks and hundreds of peer-reviewed academic articles. Dr. Tina Alster has been an advisor to reputed global beauty companies on premium product development, including to L’Oréal (Lancôme skincare line) and Estée Lauder (La Mer skincare line). She brings to Aperio a rich knowledge of the premiere skincare marketplace and will guide the Company towards optimizing current and forward product lines and downstream strategic relationships.